Skip to content
MARKETS / NASDAQ / SRTA
NASDAQ · SERVICES-HEALTH SERVICES · MID CAP

Strata Critical Medical, Inc. SRTA

7 fiscal years on record · USD · FY2025 reported · SEC filings only
$197.1M
▲ 34.3% YoY
$41.3M
$-58.5M
In brief

What this company does

Strata Critical Medical, Inc. is a time-critical logistics and medical services provider to the United States healthcare industry. As of December 31, 2025, the company employed 601 employees, all of whom were located across the United States. Strata operates across two operating segments, Logistics and Clinical, offering a variety of logistics and clinical services related to organ transplant and the broader healthcare industry. Its Logistics segment, marketed under the Trinity brand name, provides air and ground transportation of human organs for transplant along with related staff, equipment, blood samples and tissue samples, as well as organ placement services coordinating the acceptance of potential donor organs for recipients. Its Clinical segment, marketed under the Keystone brand name, includes surgical organ recovery, normothermic regional perfusion and preservation of donor organs, along with cardiac perfusion, blood management and extracorporeal membrane oxygenation services for hospitals. The company's predecessor was a special purpose acquisition company incorporated in Delaware in 2019 as Experience Investment Corp., which in 2021 acquired Blade Urban Air Mobility, Inc. and changed its name to Blade Air Mobility, Inc. Following the August 2025 divestiture of its legacy passenger mobility business, the company rebranded as Strata Critical Medical, Inc.

Written from the business description in Strata Critical Medical, Inc.'s annual report to the U.S. Securities and Exchange Commission, filed 3 March 2026. Every sentence was checked against that document before publication.

Growth
USD 197.1M
Revenue, FY2025 · full 7-year series below
Revenue $M Net income $M
FY2025 · Revenue 197.1 · Net income 41.3
80M160M-20M-40M2019202020212022202320242025
Compound annual growth
+10.5%
+53.1%
3 yrs
5 yrs
10 yrs
15 yrs

Revenue compounded at +53.1% a year over five years.

Compound annual rates per period — left blank where that exact year isn't on file, the series crosses a loss, or (per-share rows) a split falls inside the window.

Profitability
21 cents
of every revenue dollar became profit
Operating margin Net margin
FY2025 · Operating -11.3% · Net 21.0%
10%20%-50%2019202020212022202320242025
ROE
FY2025 · ROE 16.5%
5%10%15%-20%-40%-60%2019202020212022202320242025

Each USD of equity produced 17 cents of profit this year.

Cash & shareholders
returned in FY2025 · dividends + net buybacks
Free cash flow $M
FY2025 · FCF -58.5
-20M-40M2019202020212022202320242025
Net buybacks $ Dividends $
FY2025 · Dividends — · Net buybacks -193000.0
40000-80000-160000202320242025

Total assetsUSD 325.5M
EquityUSD 279.1M
CashUSD 31.0M
Current ratio6.38×

Equity funds 86% of total assets.

The 7-year record
7 fiscal years
Every figure from documents filed with the SEC · USD

EPS, diluted, dividend per share and shares outstanding are shown without shading, and a vertical line marks the year the share count changed — the series crosses a large, unexplained change in share count, so the years on either side are not on a comparable scale.

row low → row highnegative
Metric 2025202420232022202120202019
Revenue $B0.20.10.20.10.10.00.0
Operating income $B−0.0−0.0−0.1−0.1−0.0−0.0−0.0
EBITDA $B−0.0−0.0−0.1−0.0−0.0−0.0−0.0
Income tax $B0.00.0−0.0−0.0−0.00.00.0
Net income $B0.0−0.0−0.1−0.0−0.0−0.0−0.0
Free cash flow $B−0.1−0.0−0.0−0.0−0.0−0.0−0.0
EPS, diluted $0.50−0.35−0.76−0.38−0.93−0.40−0.43
Dividend / sh $·······
Payout %·······
ROE %16.5−12.0−22.0−9.6−26.5−63.9−52.3

Slide the table for earlier years · "·" marks a figure not available in our data for that year.

Provenance
Company facts, as filed
How we verify · 0 failures in 30 reconciliationsAUDITED

Reconciled in 7 of 19 fiscal years. 60 checks could not be computed.

EPS recomputationBalance-sheet identityGross profitBalance-sheet liquiditymoeda_consistente0 failures
ActivityServices-Health Services
Listed onNASDAQ
Incorporated inDelaware
Fiscal year endsDecember 31
Data on record since2019

Share this section

Download image